Simpler Grants.gov #360549

NIH Kidney Precision Medicine Project – Recruitment Sites Sought

This opportunity from the National Institutes of Health (NIH) seeks applications for Recruitment Sites under the Kidney Precision Medicine Project (KPMP). - Government Buyer: - National Institutes of Health (NIH) - Diabetes, Digestive, and Kidney Diseases Extramural Research program - Project Scope: - Establish Recruitment Sites to enroll participants with acute kidney injury (AKI) and/or chronic kidney disease (CKD) - Conduct protocol-based research kidney biopsies - Collaborate with Tissue Interrogation Sites (TIS), the Kidney Tissue Atlas Coordinating Center (KTACC), and the Central Hub (CH) - Collect and analyze kidney biopsies to create a Kidney Tissue Atlas - Define disease subgroups and identify critical cells, interstitial components, pathways, and therapeutic targets - Funding and Awards: - Estimated total program funding: $4,000,000 - Approximately 7 awards expected - Funding instrument: Cooperative agreement - Eligibility: - Open to nonprofits, businesses, government entities, educational institutions, and others - Notable Requirements: - No specific OEMs, vendors, products, or part numbers are identified - Emphasis on collaboration and protocol-driven research - Focus on advancing kidney disease research through participant recruitment and biospecimen analysis

Description

This Notice of Funding Opportunity (NOFO) requests applications for the Kidney Precision Medicine Project (KPMP) - Recruitment Sites (RS) to enroll participants with either acute kidney injury (AKI) and/or chronic kidney disease (CKD) into a longitudinal cohort study and perform protocol-based research kidney biopsies. The RS will collaborate with the Tissue Interrogation Sites (TIS), Kidney Tissue Atlas Coordinating Center (KTACC), and Central Hub (CH) to obtain and evaluate kidney biopsies from participants, create a Kidney Tissue Atlas, define disease subgroups, and identify critical cells, interstitial components, pathways, and targets for novel therapies. The funding instrument type is a cooperative agreement with an estimated program funding of $4,000,000 and expected awards of 7. The estimated application due date is October 5, 2026, with an estimated award date of June 1, 2027, and project start date of July 1, 2027.

View original listing